510(k) K920289
K920289 is an FDA 510(k) premarket notification submitted by Cordis Corp. for the device "CORDIS BIPAL 7 BIOPSY FORCEPS". The FDA issued a decision of Substantially Equivalent on March 30, 1992. The device falls under product code DWZ (Device, Biopsy, Endomyocardial), a Class II device regulated under 21 CFR 870.4075. Cordis Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 30, 1992
- Date Received
- January 22, 1992
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Device, Biopsy, Endomyocardial
- Device Class
- Class II
- Regulation Number
- 870.4075
- Review Panel
- CV
- Submission Type